Combination of Bevacizumab and Lomustine with First Recurrence of Glioblastoma Prolongs PFS but not OS
Results of EORTC trial 26101 presented today at The 20th [...]
Late effects of treatment study continues sustained academic effort in Hodgkin’s lymphoma
Early diagnosis, targeted therapeutics, and more personalized multimodal treatments have [...]
14M Genomics and EORTC and Announce First Results from their Collaboration on Tumour Profiling
Cambridge, UK - 14M Genomics (“14MG”) and The European Organisation [...]
FDA Approves Adjuvant Yervoy in Melanoma based on results of EORTC trial 18071
Based on the results of EORTC trial 18071, the FDA [...]
Will HER-2 targeted treatment improve the efficacy of chemotherapy for early HER-2 positive gastric cancer?
The prognosis for patients with gastric cancer is poor. In [...]
New deal in clinical research for surgical oncology
Hear Prof Serge Evrard (photo) to talk at the ECC 2015 [...]
Enrollment of first patient in a Phase II trabectedin study in brain tumor type called meningioma
Madrid, September 21st, 2015: EORTC and PharmaMar [...]
EORTC Statistics Department recognized by 2015 FLAMES award
FLAMES, the Flanders' Training Network for Methodology and Statistics, has [...]
Denis Lacombe quietly orchestrating the clinical research revolution
Read what EORTC Director General Denis Lacombe has to say about [...]
EORTC trial evaluating functional imaging for patients with non-small cell lung cancer
Each year well over one million patients die of non-small [...]
